Mathematical Expansion and Clinical Application of Chronic Kidney Disease Stage As Vector Field

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 Mar 13

PMID 38478478

Authors

Eiichiro Kanda

Bogdan I Epureanu

Taiji Adachi

Tamaki Sasaki

Naoki Kashihara

Affiliations

Soon will be listed here.

Abstract

There are cases in which CKD progression is difficult to evaluate, because the changes in estimated glomerular filtration rate (eGFR) and proteinuria sometimes show opposite directions as CKD progresses. Indices and models that enable the easy and accurate risk prediction of end-stage-kidney disease (ESKD) are indispensable to CKD therapy. In this study, we investigated whether a CKD stage coordinate transformed into a vector field (CKD potential model) accurately predicts ESKD risk. Meta-analysis of large-scale cohort studies of CKD patients in PubMed was conducted to develop the model. The distance from CKD stage G2 A1 to a patient's data on eGFR and proteinuria was defined as r. We developed the CKD potential model on the basis of the data from the meta-analysis of three previous cohort studies: ESKD risk = exp(r). Then, the model was validated using data from a cohort study of CKD patients in Japan followed up for three years (n = 1,564). Moreover, the directional derivative of the model was developed as an index of CKD progression velocity. For ESKD prediction in three years, areas under the receiver operating characteristic curves (AUCs) were adjusted for baseline characteristics. Cox proportional hazards models with spline terms showed the exponential association between r and ESKD risk (p<0.0001). The CKD potential model more accurately predicted ESKD with an adjusted AUC of 0.81 (95% CI 0.76, 0.87) than eGFR (p<0.0001). Moreover, the directional derivative of the model showed a larger adjusted AUC for the prediction of ESKD than the percent eGFR change and eGFR slope (p<0.0001). Then, a chart of the transformed CKD stage was developed for implementation in clinical settings. This study indicated that the transformed CKD stage as a vector field enables the easy and accurate estimation of ESKD risk and CKD progression and suggested that vector analysis is a useful tool for clinical studies of CKD and its related diseases.

References

Kanda E, Epureanu B, Adachi T, Kashihara N . Machine-learning-based Web system for the prediction of chronic kidney disease progression and mortality. PLOS Digit Health. 2023; 2(1):e0000188. PMC: 9931312. DOI: 10.1371/journal.pdig.0000188. View

Norris K, Smoyer K, Rolland C, Van der Vaart J, Grubb E . Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review. BMC Nephrol. 2018; 19(1):36. PMC: 5807748. DOI: 10.1186/s12882-018-0821-9. View

Berhane A, Weil E, Knowler W, Nelson R, Hanson R . Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death. Clin J Am Soc Nephrol. 2011; 6(10):2444-51. PMC: 3186453. DOI: 10.2215/CJN.00580111. View

Gansevoort R, Correa-Rotter R, Hemmelgarn B, Jafar T, Lambers Heerspink H, Mann J . Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013; 382(9889):339-52. DOI: 10.1016/S0140-6736(13)60595-4. View

Amin A, Whaley-Connell A, Li S, Chen S, McCullough P, Kosiborod M . The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2013; 61(4 Suppl 2):S12-23. PMC: 4492431. DOI: 10.1053/j.ajkd.2013.01.005. View

Weng S, Chen C, Chen Y, Wu M, Tarng D . Trajectory of Estimated Glomerular Filtration Rate and Malnourishment Predict Mortality and Kidney Failure in Older Adults With Chronic Kidney Disease. Front Med (Lausanne). 2021; 8:760391. PMC: 8666586. DOI: 10.3389/fmed.2021.760391. View

Astor B, Matsushita K, Gansevoort R, van der Velde M, Woodward M, Levey A . Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011; 79(12):1331-40. PMC: 3917543. DOI: 10.1038/ki.2010.550. View

Wada T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K . Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol. 2013; 18(4):613-20. DOI: 10.1007/s10157-013-0879-4. View

Xie Y, Bowe B, Xian H, Balasubramanian S, Al-Aly Z . Renal Function Trajectories in Patients with Prior Improved eGFR Slopes and Risk of Death. PLoS One. 2016; 11(2):e0149283. PMC: 4762675. DOI: 10.1371/journal.pone.0149283. View

10.

Matsushita K, van der Velde M, Astor B, Woodward M, Levey A, de Jong P . Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010; 375(9731):2073-81. PMC: 3993088. DOI: 10.1016/S0140-6736(10)60674-5. View

11.

Sugawara Y, Kanda E, Ohsugi M, Ueki K, Kashihara N, Nangaku M . eGFR slope as a surrogate endpoint for end-stage kidney disease in patients with diabetes and eGFR > 30 mL/min/1.73 m in the J-DREAMS cohort. Clin Exp Nephrol. 2023; 28(2):144-152. PMC: 10808312. DOI: 10.1007/s10157-023-02408-z. View

12.

Chang A, Kramer H . Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney disease and cardiovascular disease risk prediction. Nephron Clin Pract. 2011; 119(2):c171-7. DOI: 10.1159/000325669. View

13.

Go A, Chertow G, Fan D, McCulloch C, Hsu C . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351(13):1296-305. DOI: 10.1056/NEJMoa041031. View

14.

Oshima M, Shimizu M, Yamanouchi M, Toyama T, Hara A, Furuichi K . Trajectories of kidney function in diabetes: a clinicopathological update. Nat Rev Nephrol. 2021; 17(11):740-750. DOI: 10.1038/s41581-021-00462-y. View

15.

. Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018. Clin Exp Nephrol. 2018; 23(1):1-15. PMC: 6344397. DOI: 10.1007/s10157-018-1648-1. View

16.

. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011). 2019; 7(1):1-59. PMC: 6340919. DOI: 10.1016/j.kisu.2017.04.001. View

17.

Matsushita K, Chen J, Sang Y, Ballew S, Shimazaki R, Fukagawa M . Risk of end-stage renal disease in Japanese patients with chronic kidney disease increases proportionately to decline in estimated glomerular filtration rate. Kidney Int. 2016; 90(5):1109-1114. DOI: 10.1016/j.kint.2016.08.003. View

18.

Leffondre K, Boucquemont J, Tripepi G, Stel V, Heinze G, Dunkler D . Analysis of risk factors associated with renal function trajectory over time: a comparison of different statistical approaches. Nephrol Dial Transplant. 2014; 30(8):1237-43. DOI: 10.1093/ndt/gfu320. View

19.

Levey A, Gansevoort R, Coresh J, Inker L, Heerspink H, Grams M . Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency. Am J Kidney Dis. 2019; 75(1):84-104. DOI: 10.1053/j.ajkd.2019.06.009. View

20.

Weldegiorgis M, de Zeeuw D, Li L, Parving H, Hou F, Remuzzi G . Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy. Am J Kidney Dis. 2017; 71(1):91-101. DOI: 10.1053/j.ajkd.2017.08.010. View